On March 22, the Federal Government announced its long-awaited strategy for increasing equitable and affordable access to effective medications for rare diseases. On Tuesday, April 4 at 1 pm ET CEO Sandra Hanna and VP of Pharmacy Affairs Shelita Dattani held a wide-ranging discussion of how this strategy will impact community pharmacy . Follow us on LinkedIn for more.
National Strategy for Drugs for Rare Diseases: What Does This Mean for Pharmacy?
